COREY S GOODMAN

CIK 1278411 · Senior Vice President · last filed 2026-02-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.36M

Companies

7

Total Filings

45

Lifetime Open-Market Net

$38.83M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALXO Director 113,287 $1.58 $179.0K $21.15M 9 2026-02-04
Ventyx Biosciences, Inc. (VTYX) Delisted 10%+ Owner $13.99 $0 1 2022-06-10
Checkmate Pharmaceuticals, Inc. (CMPI) Delisted 10%+ Owner 2,514,415 $10.50 $26.40M -$14.36M 2 2022-05-09
IPI Legacy Liquidation Co (IMPL) Delisted 10%+ Owner 2,309,791 $0.24 $556.9K $33.75M 1 2021-04-29
Akero Therapeutics, Inc. (AKRO) Delisted 10%+ Owner 3,940,534 $54.65 $215.35M -$1.72M 1 2020-01-03
PFE Senior Vice President 83,327 $26.21 $2.18M $0 27 2009-05-01
RENOVIS INC (RNVS) Delisted President and CEO 558,218 $0 3 2008-02-12

Recent Filings · Page 2 of 5

45 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-04-29 IPI Legacy Liquidation Co (IMPL) Delisted Mixed +13,798,955 $33.75M EDGAR
2020-07-21 ALXO Mixed +8,038,585 $16.15M EDGAR
2020-07-17 ALXO Grant (A) $0 EDGAR
2020-01-03 Akero Therapeutics, Inc. (AKRO) Delisted Sell (S) −71,620 -$1.72M EDGAR
2009-05-01 PFE Grant (A) $0 EDGAR
2009-04-16 PFE Grant (A) $0 EDGAR
2009-04-01 PFE Grant (A) $0 EDGAR
2009-03-16 PFE Grant (A) $0 EDGAR
2009-03-02 PFE Grant (A) +51,865 $0 EDGAR
2009-01-05 PFE Grant (A) $0 EDGAR
Showing 1120 of 45
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.